This week we highlight new guidance from the U.S. Food and Drug Administration on ensuring that clinical trials are inclusive, Biogen’s challenges with marketing its new Alzheimer’s drug, a COVID-19 breathalyzer and how a new type of T cell could allow better targeting of solid tumors. Finally, we look at ... READ MORE >
5 things to know in life sciences: Week of April 4, 2022
This week we highlight a slow start to the year for life sciences initial public offerings, Medicare’s decision on Alzheimer’s disease reimbursement, the use of machine learning and artificial intelligence in clinical trials and the rapidly growing market for virtual trials. Finally, we look at how the ... READ MORE >
5 things to know in life sciences: Week of March 28, 2022
This week we highlight a Food and Drug Administration approval for an alternative to LASIK, promising results for a less invasive brain interface device and a precision biotech who has recently raised an additional $100 million in funding. Finally, we look at additional FDA approvals for a wearable ... READ MORE >
5 things to know in life sciences: Week of March 21, 2022
This week we highlight continued investment in virtual trials, robotic injections, costs of COVID-19 treatments and the need to understand drug safety for pregnant patients. Finally, we look at the most recent round of drug pricing reform in Congress which aims to reduce insulin prices. Each week we ... READ MORE >
5 things to know in life sciences: Week of March 14, 2022
This week we highlight patent infringement claims, ongoing manufacturing expansion, underrepresentation of pregnant women in clinical data, and the National Institutes of Health’s All of Us genomic study. Each week we highlight five things you need to know about in the life sciences industry. Here’s the ... READ MORE >
5 things to know in life sciences: Week of March 7, 2022
This week we highlight changes in drug exclusivity, international mRNA manufacturing expansion, clinical trial challenges in Russia, and recent Food and Drug Administration activities. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Top 10 ... READ MORE >
5 things to know in life sciences: Week of Feb. 28, 2022
This week we highlight clinical holds on cell and gene therapies, clinical trials and patient experience, artificial intelligence and identifying bone fractures, and more. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Cell and gene therapies ... READ MORE >
5 things to know in life sciences: Week of Feb. 21, 2022
This week we highlight a personalized blood testing company, an artificial intelligence-based software platform capable of detecting heart disease and a promising mRNA technology that can heal bone defects. In addition, we look at a novel company providing a kidney care solution as well as Nintendo and ... READ MORE >
5 things to know in life sciences: Week of Feb. 14, 2022
This week, we highlight Moderna’s contract extension with Rovi, a recent report that indicates the global contract development and manufacturing organization (CDMO) market is expected to grow by over $8.65 billion by 2026, Robert Califf’s return as Food and Drug Administration commissioner, an artificial ... READ MORE >
5 things to know in life sciences: Week of Feb. 7, 2022
This week we highlight regulatory challenges for the United States and China; a softening of guidelines in the prescription of opioids; and record-breaking sales figures for Pfizer as it sees a more than 600% increase in vaccine revenue. Finally, we look at a new cartilage implant inspired by spiders and ... READ MORE >